{"id":"W4296969016","doi":"10.1016/s2152-2650(22)01000-x","title":"Poster: ABCL-073 Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (Pola-R-CHP) Versus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP) Therapy in Patients With Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): Results From the Phase III POLARIX Study","year":2022,"lang":"en","type":"article","venue":"Clinical Lymphoma Myeloma & Leukemia","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Roche (Canada); Sunnybrook Health Science Centre; Health Sciences Centre; Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Prednisone; Rituximab; Cyclophosphamide; Vincristine; Medicine; Doxorubicin; CHOP; Internal medicine; Oncology; Chemotherapy; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008797257,0.0007143929,0.001319985,0.0002182508,0.0002568362,0.0008952116,0.0005824918,0.0008072563,0.007201567],"category_scores_gemma":[0.0006550954,0.0003180523,0.001028074,0.0002663211,0.0005698403,0.000509265,0.0002622076,0.002130938,0.001140693],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008481055,"about_ca_system_score_gemma":0.0008287991,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001487604,"about_ca_topic_score_gemma":0.002774818,"domain_scores_codex":[0.9997402,0.0001314616,0.00001240504,0.00004069031,0.00002280455,0.00005253188],"domain_scores_gemma":[0.9996233,0.0001254497,0.00005648016,0.00001521907,0.00002020671,0.000159255],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8814816,0.008162745,0.002522792,0.0004665559,0.001469696,0.00008783262,0.00007287799,0.001575933,0.0105064,0.0002385062,0.007180301,0.08623483],"study_design_scores_gemma":[0.6864485,0.270687,0.02644376,0.00009219737,0.001927007,0.0002528569,0.00008449276,0.001592309,0.003290038,0.0002919979,0.008849147,0.00004059887],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.980269,0.008230005,0.0003564886,0.001818611,0.0007045924,0.0005258871,0.002015812,0.0001188741,0.005960603],"genre_scores_gemma":[0.982828,0.004627826,0.0006569662,0.001678461,0.0005028416,0.0003373978,0.002598651,0.00004271439,0.006727134],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007201567,"threshold_uncertainty_score":0.0240916,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01576506250890463,"score_gpt":0.2811204971392092,"score_spread":0.2653554346303046,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}